Molecular mechanism of emotional fever - The role of nitric oxide

Journal of Physiology and Pharmacology

Volumn 57, Issue SUPPL. 8, 2006, Pages 51-59

  Soszyński, Dariusz ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Aminoguanidine; Biotelemetry; Nitric oxide synthase; Open field; Rat; Stress fever; vL NIO

Indexed keywords

AMINOGUANIDINE; INDUCIBLE NITRIC OXIDE SYNTHASE; N 5 (1 IMINO 3 BUTENYL)ORNITHINE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; BODY TEMPERATURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEVER; LATERAL BRAIN VENTRICLE; LOCOMOTION; MALE; MENTAL STRESS; MOTOR ACTIVITY; NONHUMAN; OPEN FIELD BEHAVIOR; RAT; TELEMETRY;

ANIMALS; BODY TEMPERATURE; ENZYME ACTIVATION; ENZYME INHIBITORS; FEVER; GUANIDINES; INJECTIONS, INTRAVENTRICULAR; MALE; MOTOR ACTIVITY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; ORNITHINE; RATS; RATS, WISTAR; STRESS; TELEMETRY;

EID: 34047261759     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Long NC, Vander AJ, Kluger MJ. Stress-induced rise of body temperature in rats is the same in warm and cool environments. Physiol Behav 1990; 47: 773-775.
2. Briese E, Cabanac M. Stress hyperthermia: physiological arguments that it is a fever. Physiol Behav 1991; 49: 1153-1157.
3. Caputa M. Selective brain cooling: a multiple regulatory mechanism. J Therm Biol 2004; 29: 691-702.
4. Kluger MJ, Kozak W, Leon LR, Soszynski D, Conn CA. Cytokines and fever. Neuroimmunomodulation 1995; 2:216-223.
5. Milton AS. Prostaglandins and fever. Prog Brain Res 1998; 115: 129-139.
6. Kluger MJ, O'Reilly B, Shope TR, Vander AJ. Further evidence that stress hyperthermia is a fever. Physiol Behav 1995; 2: 216-223.
7. Singer R, Harker CT, Vander AJ, Kluger MJ. Hyperthermia induced by open-field stress is blocked by salicylate. Physiol Behav 1986; 36: 1179-1182.
8. Long NC, Kluger MJ, Vander AJ. Antiserum against mouse IL-1 alpha does not block stress hyperthermia or LPS fever in the rat. In Thermoregulation Research and Clinical Application, P Lomax, E Schonbaum (eds). Basel, Karger, 1989, pp. 78-84.
9. Kozak W, Zheng H, Conn CA, Soszynski D, Van der Ploeg LHT, Kluger MJ. Thermal and behavioral effects of lipopolisaccharide and influenza in interleukin-1β-deficient mice. Am J Physiol 1995; 269: R969-R977.
10. Kozak W, Poli V, Soszynski D, Conn CA, Leon LR, Kluger MJ. Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis. Am J Physiol 1997; 272: R1298-R1307.
11. Soszynski D, Kozak W, Kluger MJ. Endotoxin tolerancje does not alter open field-induced feler in rats. Physiol Behav 1998; 63: 689-692.
12. Soszynski D, Kozak W, Conn CA, Rudolph K, Kluger MJ. Beta-adrenoceptor antagonists suppress elevation in body temperature and increase in plasma IL-6 in rats expose to open field. Neuroendocrinology 1996; 63: 459-467.
13. Mayfield KP, Soszynski D, Kozak W, Kozak A, Rudolph K, Kluger MJ. β-adrenergic receptor subtype effects on stress fever and thermoregulation. Neuroimmunomodulation 1999; 6: 305-317.
14. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
15. Soszynski D. The inhibition of of nitric oxide synthase suppresses LPS- and psychological stress-induced fever in rats. Physiol Behav 2001; 72: 65-72.
16. Kozak W, Kozak A. Differential role of nitric oxide synthase isoforms in fever of different etiologiest: studies using NOS gene-deficient mice. J Appl Physiol 2003; 94: 2534-2544.
17. Dwyer MA, Bredt DS, Snyder SH. Nitric oxide synthase: irreversible inhibition by L-NG-nitroarginine in brain in vitro and in vivo. Biophys Res Commun 1991; 176: 1136-1141.
18. Pellegrino LJ, Pellegrino AS, Cushman AJ. A stereotaxic atlas of the rat brain. New York, Plenum Press, 1979.
19. Chabrier PE, Demerle-Pallardy C, Auguet M. Nitric oxide synthases: targets for therapeutic strategies in neurological disesases. Cell Mol Life Sci 1999; 55: 1029-1035.
20. Griffith OW, Stuehr DJ. Nitric oxide synthases: properties and catalytic mechanism. Ann Rev Physiol 1995; 57: 707-736.
21. Monti JM, Jantos H. Microinjection of the nitric oxide synthase inhibitor l-NAME into the lateral basal forebrain alters the sleep/wake cycle of the rat. Prog Neuro-Psychopharmacol Biol Psych 2004; 28: 239-247.
22. Gath I, Benamar K, Jurat G, Roth J, Simon E, Schmid HA. Expression of nitric oxide synthase (NOS) isoforms in rat brain during lipopolysaccharide- induced fever. Pflugers Arch 1999; 437: R143.
23. Vincent SR, Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 1992; 46: 755-784.
24. Perkins DJ, Kniss DA. Blockade of nitric oxide formation down-regulates cyclooxygenase-2 and decrease PGE2 biosynthesis in macrophages. J Leukocyte Biol 1999; 65: 792-799.
25. Dunn AJ. Brain catecholaminergic and tryptophan responses to restraint are attenuated by nitric oxide synthase inhibition. Neurochem Int 1999; 33: 551-557.